Search

Search bills, members, committees and pages...

Sign In

VERONICA JACKSON

PreviousNext

90 federal lobbying filings, 2023 to 2026.

VERONICA JACKSON is a registered lobbyist named on 90 federal lobbying filings, 2023 to 2026, reporting $3.4M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

3 they have filed under, by filings.

RegistrantFilingsReported
ALB SOLUTIONS65$2.8M
SALT POINT STRATEGIES16$570K
HUMANA, INC.9—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202633$1.3M—
202549$2.1M$2.5M
20244—$4.8M
20234—$4.9M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues60
PHAPharmacy18
MMMMedicare/Medicaid15
TAXTaxation/Internal Revenue Code11
DEFDefense9
MANManufacturing6
TARTariff (miscellaneous tariff bills)6
TRDTrade (domestic/foreign)6
SPOSports/Athletics3

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.Con.Res. 14Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…1
H.R. 5009Fine Arts Protection Act of 20251
H.R. 8702Secret Service Transfer Act of 20261
S. 4532Small Business Wildfire Smoke Recovery Act1
S.Con.Res. 7An original concurrent resolution setting forth the congressional budget for the United States Government for…1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
VERTEX PHARMACEUTICALSALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATIONALB SOLUTIONS2026 second_quarter$30KJul 16, 2026
INDEPENDENCE BLUE CROSSALB SOLUTIONS2026 second_quarter$40KJul 16, 2026
HUMANA, INC.ALB SOLUTIONS2026 second_quarter$60KJul 16, 2026
ELEVANCE HEALTH, INC.ALB SOLUTIONS2026 second_quarter$60KJul 16, 2026
CVS HEALTH (AND SUBSIDIARIES)ALB SOLUTIONS2026 second_quarter$70KJul 16, 2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
CENTENE CORPORATIONSALB SOLUTIONS2026 second_quarter$30KJul 16, 2026
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.ALB SOLUTIONS2026 second_quarter$40KJul 16, 2026
BLUE CROSS AND BLUE SHIELD ASSOCIATIONALB SOLUTIONS2026 second_quarter$60KJul 16, 2026
BLOOD CANCER UNITEDALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
BETTER SOLUTIONS FOR HEALTHCAREALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
AMERICAN HEART ASSOCIATIONALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
AIS HEALTHCAREALB SOLUTIONS2026 second_quarter$50KJul 16, 2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS2026 first_quarter$50KApr 17, 2026
INDEPENDENCE BLUE CROSSSALT POINT STRATEGIES2026 first_quarter—Apr 17, 2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS2026 first_quarter—Apr 15, 2026
VERTEX PHARMACEUTICALSALB SOLUTIONS2026 first_quarter$50KApr 15, 2026
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATIONALB SOLUTIONS2026 first_quarter$30KApr 15, 2026
INDEPENDENCE BLUE CROSSALB SOLUTIONS2026 first_quarter$40KApr 15, 2026
HUMANA, INC.ALB SOLUTIONS2026 first_quarter$60KApr 15, 2026
ELEVANCE HEALTH, INC.ALB SOLUTIONS2026 first_quarter$60KApr 15, 2026
CVS HEALTH (AND SUBSIDIARIES)ALB SOLUTIONS2026 first_quarter$70KApr 15, 2026
CENTENE CORPORATIONSALB SOLUTIONS2026 first_quarter$30KApr 15, 2026
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.ALB SOLUTIONS2026 first_quarter$40KApr 15, 2026